Tag: MiniMed
Medtronic’s MiniMed board sees shake up
May 19, 2026HME News Staff
NORTHRIDGE, Calif. – Brett Wall, a class II director of MiniMed Group’s board of directors, has resigned following his departure as executive vice president and president of the neurosciences portfolio of Medtronic, the parent company of MiniMed, according to a Securities and Exchange Commission (SEC) filing. Wall, who was also a member of the board’s Nominating and Corporate Governance Committee, was nominated to the MiniMed board by Medtronic. Scott Cundy will fill his vacancy...
In brief: Conduit Health’s raise, Quipt’s new phase, MiniMed’s debut
March 17, 2026HME News Staff
NEW YORK – Conduit Health, a consumer-oriented provider of insurance-covered medical supplies and services for Medicare and Medicaid patients, has announced a $17 million Series A to expand its vertically-integrated model that it says brings clinical care, insurance authorization and medical supply fulfillment together under one coordinated structure.
In just 16 months since its public launch, Conduit has delivered supplies to more than 50,000 patients, while increasing its product catalog...
Medtronic’s MiniMed joins Nasdaq
March 17, 2026HME News Staff
GALWAY, Ireland, and NORTHRIDGE, Calif. – MiniMed Group, a subsidiary of Medtronic, has begun trading on the Nasdaq under the ticker symbol “MMED” in connection with its initial public offering (IPO). "Today marks an exciting milestone for both MiniMed and Medtronic,” said Geoff Martha, Medtronic chairman and CEO. “Despite a challenging market backdrop shaped by geopolitical uncertainty, the teams successfully executed an oversubscribed offering and the second largest...
Medtronic reports Q3 earnings, sees diabetes growth
February 17, 2026HME News Staff
GALWAY, Ireland – Medtronic reported revenue of $9 billion for its third quarter of fiscal year 2026 (FY26), which ended Jan. 23, 2026. Of that, diabetes business revenue was $796 million, an increase of 14.8% as reported and 8.3% organic, led by double-digit strength in international markets. In May 2025, Medtronic announced it would separate its diabetes business into a new standalone company, which represented 8% of revenue and 4% of segment operating profit...
In brief: Cardinal, Medtronic stand up Rx channels for diabetes
January 13, 2026HME News Staff
DUBLIN, Ohio – Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail pharmacies seamlessly refer patients to Cardinal Health at-Home Solutions for the fulfillment and home delivery of diabetes supplies, including continuous glucose monitors (CGMs).
“Providing diabetic supplies to patients covered under a medical benefit can create administrative burden on a pharmacy,” said Rob Schlissberg,...
Medtronic builds pharmacy channel for MiniMed insulin pump
January 12, 2026HME News Staff
MINNEAPOLIS – Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with major pharmacy benefit managers (PBMs) and group purchasing organizations (GPOs), including Ascent and Zinc.
These agreements also include access to the company's expanded CGM portfolio – Simplera sensor, Simplera Sync sensor, and Instinct sensor, made by Abbott – and build...
Medtronic starts IPO process for MiniMed
December 23, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced that its diabetes business, which will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common stock. The separation is expected to be completed through a series of capital markets transactions, with a preferred path of an IPO and subsequent split-off. MiniMed intends...
Medtronic rolls out MiniMed 780G insulin pump system with Instinct sensor in US
December 5, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced the broad U.S. commercial launch of the MiniMed 780G insulin pump system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems. The Instinct sensor is based on Abbott's most advanced continuous glucose monitoring (CGM) technology, featuring a small discreet sensor with a wear time of up to 15 days. When paired with the MiniMed 780G system,...